Low Serum miR-607 Level as a Potential Diagnostic and Prognostic Biomarker in Patients of Pancreatic Ductal Adenocarcinoma: A Preliminary Study

Figure 3

Kaplan–Meier survival curves for patients with PDAC based on miR-607 expression status. (a) Low miR-607 expression group had a significantly shorter OS than high miR-607 expression group. (b) The PFS was significantly worse in PDAC patients with low miR-607 expression than in those patients with high miR-607 expression. (c) qRT-PCR analysis of miR-607 expression levels in PDAC patients before and after surgery. OS: overall survival, PFS: progression-free survival.

(a)

(b)

(c)